A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector
Dworaczyk, David A., Hunt, Allen L., Di Spirito, Mike, Lor, Mary, Dretchen, Kenneth L., Lamson, Michael J., Pollock, Jonathan, Ward, Thelma
Published in The journal of allergy and clinical immunology. Global (01.05.2024)
Published in The journal of allergy and clinical immunology. Global (01.05.2024)
Get full text
Journal Article
Randomized trial of pharmacokinetic and pharmacodynamic effects of 13.2 mg intranasal epinephrine treatment in congestion
Dworaczyk, David A., Hunt, Allen, Di Spirito, Mike, Lor, Mary, Rance, Karen, van Haarst, Aernout D.
Published in Annals of allergy, asthma, & immunology (01.08.2024)
Published in Annals of allergy, asthma, & immunology (01.08.2024)
Get full text
Journal Article